1 Market Overview of Lung Pulmonary Airway Disease Treatment 1.1 Lung Pulmonary Airway Disease Treatment Market Overview 1.1.1 Lung Pulmonary Airway Disease Treatment Product Scope 1.1.2 Lung Pulmonary Airway Disease Treatment Market Status and Outlook 1.2 Global Lung Pulmonary Airway Disease Treatment Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Lung Pulmonary Airway Disease Treatment Market Size by Region (2016-2027) 1.4 Global Lung Pulmonary Airway Disease Treatment Historic Market Size by Region (2016-2021) 1.5 Global Lung Pulmonary Airway Disease Treatment Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) 1.6.1 North America Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) 1.6.2 Europe Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) 1.6.3 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) 1.6.4 Latin America Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) 1.6.5 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) 2 Lung Pulmonary Airway Disease Treatment Market Overview by Type 2.1 Global Lung Pulmonary Airway Disease Treatment Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Lung Pulmonary Airway Disease Treatment Historic Market Size by Type (2016-2021) 2.3 Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Type (2022-2027) 2.4 Bronchodilators 2.5 Cytotoxic Drugs 2.6 Antibiotics 2.7 Others 3 Lung Pulmonary Airway Disease Treatment Market Overview by Application 3.1 Global Lung Pulmonary Airway Disease Treatment Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Lung Pulmonary Airway Disease Treatment Historic Market Size by Application (2016-2021) 3.3 Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Application (2022-2027) 3.4 Hospital 3.5 Clinic 3.6 Others 4 Lung Pulmonary Airway Disease Treatment Competition Analysis by Players 4.1 Global Lung Pulmonary Airway Disease Treatment Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Pulmonary Airway Disease Treatment as of 2020) 4.3 Date of Key Players Enter into Lung Pulmonary Airway Disease Treatment Market 4.4 Global Top Players Lung Pulmonary Airway Disease Treatment Headquarters and Area Served 4.5 Key Players Lung Pulmonary Airway Disease Treatment Product Solution and Service 4.6 Competitive Status 4.6.1 Lung Pulmonary Airway Disease Treatment Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Boehringer Ingelheim International 5.1.1 Boehringer Ingelheim International Profile 5.1.2 Boehringer Ingelheim International Main Business 5.1.3 Boehringer Ingelheim International Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.1.4 Boehringer Ingelheim International Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.1.5 Boehringer Ingelheim International Recent Developments 5.2 AstraZeneca 5.2.1 AstraZeneca Profile 5.2.2 AstraZeneca Main Business 5.2.3 AstraZeneca Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.2.4 AstraZeneca Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.2.5 AstraZeneca Recent Developments 5.3 Teva Pharmaceuticals 5.5.1 Teva Pharmaceuticals Profile 5.3.2 Teva Pharmaceuticals Main Business 5.3.3 Teva Pharmaceuticals Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.3.4 Teva Pharmaceuticals Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.3.5 GSK Recent Developments 5.4 GSK 5.4.1 GSK Profile 5.4.2 GSK Main Business 5.4.3 GSK Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.4.4 GSK Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.4.5 GSK Recent Developments 5.5 Novartis 5.5.1 Novartis Profile 5.5.2 Novartis Main Business 5.5.3 Novartis Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.5.4 Novartis Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.5.5 Novartis Recent Developments 5.6 Merck 5.6.1 Merck Profile 5.6.2 Merck Main Business 5.6.3 Merck Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.6.4 Merck Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.6.5 Merck Recent Developments 5.7 Roche 5.7.1 Roche Profile 5.7.2 Roche Main Business 5.7.3 Roche Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.7.4 Roche Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.7.5 Roche Recent Developments 5.8 Sanofi 5.8.1 Sanofi Profile 5.8.2 Sanofi Main Business 5.8.3 Sanofi Lung Pulmonary Airway Disease Treatment Products, Services and Solutions 5.8.4 Sanofi Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) & (2016-2021) 5.8.5 Sanofi Recent Developments 6 North America 6.1 North America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Lung Pulmonary Airway Disease Treatment Market Dynamics 11.1 Lung Pulmonary Airway Disease Treatment Industry Trends 11.2 Lung Pulmonary Airway Disease Treatment Market Drivers 11.3 Lung Pulmonary Airway Disease Treatment Market Challenges 11.4 Lung Pulmonary Airway Disease Treatment Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Lung Pulmonary Airway Disease Treatment Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Lung Pulmonary Airway Disease Treatment Market Size Share by Region (2016-2021) Table 4. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size Share by Region (2022-2027) Table 6. Global Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Lung Pulmonary Airway Disease Treatment Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Type (2016-2021) Table 9. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Type (2022-2027) Table 11. Global Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Lung Pulmonary Airway Disease Treatment Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Application (2016-2021) Table 14. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Application (2022-2027) Table 16. Global Lung Pulmonary Airway Disease Treatment Revenue (US$ Million) by Players (2016-2021) Table 17. Global Lung Pulmonary Airway Disease Treatment Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lung Pulmonary Airway Disease Treatment as of 2020) Table 19. Date of Key Manufacturers Enter into Lung Pulmonary Airway Disease Treatment Market Table 20. Global Lung Pulmonary Airway Disease Treatment Top Players Headquarters and Area Served Table 21. Lung Pulmonary Airway Disease Treatment Product Solution and Service Table 22. Global Lung Pulmonary Airway Disease Treatment Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Boehringer Ingelheim International Basic Information List Table 25. Boehringer Ingelheim International Description and Business Overview Table 26. Boehringer Ingelheim International Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 27. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of Boehringer Ingelheim International (2016-2021) Table 28. Boehringer Ingelheim International Recent Developments Table 29. AstraZeneca Basic Information List Table 30. AstraZeneca Description and Business Overview Table 31. AstraZeneca Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 32. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of AstraZeneca (2016-2021) Table 33. AstraZeneca Recent Developments Table 34. Teva Pharmaceuticals Basic Information List Table 35. Teva Pharmaceuticals Description and Business Overview Table 36. Teva Pharmaceuticals Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 37. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of Teva Pharmaceuticals (2016-2021) Table 38. Teva Pharmaceuticals Recent Developments Table 39. GSK Basic Information List Table 40. GSK Description and Business Overview Table 41. GSK Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 42. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of GSK (2016-2021) Table 43. GSK Recent Developments Table 44. Novartis Basic Information List Table 45. Novartis Description and Business Overview Table 46. Novartis Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 47. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of Novartis (2016-2021) Table 48. Novartis Recent Developments Table 49. Merck Basic Information List Table 50. Merck Description and Business Overview Table 51. Merck Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 52. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of Merck (2016-2021) Table 53. Merck Recent Developments Table 54. Roche Basic Information List Table 55. Roche Description and Business Overview Table 56. Roche Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 57. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of Roche (2016-2021) Table 58. Roche Recent Developments Table 59. Sanofi Basic Information List Table 60. Sanofi Description and Business Overview Table 61. Sanofi Lung Pulmonary Airway Disease Treatment Products, Services and Solutions Table 62. Revenue (US$ Million) in Lung Pulmonary Airway Disease Treatment Business of Sanofi (2016-2021) Table 63. Sanofi Recent Developments Table 64. North America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 65. North America Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 66. Europe Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 67. Europe Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 68. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region (2016-2021) & (US$ Million) Table 69. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size by Region (2022-2027) & (US$ Million) Table 70. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Share by Region (2016-2021) Table 71. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Share by Region (2022-2027) Table 72. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country (2016-2021) & (US$ Million) Table 73. Latin America Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 74. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Players (2016-2021) & (US$ Million) Table 75. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size by Country (2022-2027) & (US$ Million) Table 76. Lung Pulmonary Airway Disease Treatment Market Trends Table 77. Lung Pulmonary Airway Disease Treatment Market Drivers Table 78. Lung Pulmonary Airway Disease Treatment Market Challenges Table 79. Lung Pulmonary Airway Disease Treatment Market Restraints Table 80. Research Programs/Design for This Report Table 81. Key Data Information from Secondary Sources Table 82. Key Data Information from Primary Sources List of Figures Figure 1. Global Lung Pulmonary Airway Disease Treatment Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Lung Pulmonary Airway Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Lung Pulmonary Airway Disease Treatment Market Share by Regions: 2021 VS 2027 Figure 4. Global Lung Pulmonary Airway Disease Treatment Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Lung Pulmonary Airway Disease Treatment Market Size Share by Type in 2021 & 2027 Figure 11. Bronchodilators Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Cytotoxic Drugs Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Antibiotics Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Lung Pulmonary Airway Disease Treatment Market Size Share by Application in 2021 & 2027 Figure 16. Hospital Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Clinic Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Lung Pulmonary Airway Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 20. Global Top 5 and Top 10 Players Lung Pulmonary Airway Disease Treatment Market Share in 2020 Figure 21. North America Lung Pulmonary Airway Disease Treatment Market Share by Country (2016-2027) Figure 22. United States Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 23. Canada Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 24. Germany Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 25. France Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 26. U.K. Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 27. Italy Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 28. Russia Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 29. Nordic Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 30. Rest of Europe Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 31. Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Share by Region (2016-2027) Figure 32. China Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 33. Japan Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 34. South Korea Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 35. Southeast Asia Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 36. India Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 37. Australia Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 38. Rest of Asia-Pacific Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 39. Latin America Lung Pulmonary Airway Disease Treatment Market Share by Country (2016-2027) Figure 40. Mexico Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 41. Brazil Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 42. Rest of Latin America Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 43. Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Share by Country (2016-2027) Figure 44. Turkey Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 45. Saudi Arabia Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 46. UAE Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 47. Rest of Middle East & Africa Lung Pulmonary Airway Disease Treatment Market Size (2016-2027) & (US$ Million) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation

Boehringer Ingelheim International AstraZeneca Teva Pharmaceuticals GSK Novartis Merck Roche Sanofi